Login to Your Account



Other News To Note


Thursday, June 7, 2012
• Enamine Ltd., of Kiev, Ukraine, signed a collaboration agreement with the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge, UK, and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic (IOCB) in Prague, Czech Republic, to discover rhomboid protease inhibitors as potential drugs to treat infectious, parasitic, oncological, immune and cardiovascular diseases.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription